Background: HIV enters the nervous system soon after seroconversion. Though effects of chronic HIV infection on volumes of cortical and subcortical brain regions are well characterized, little is known about the extent of volumetric alterations that may occur within the first year of infection. We assessed brain volumes in antiretroviral therapy (ART)-naïve subjects with primary HIV infection (PHI, <1 year after initial infection) and age-matched HIV-uninfected participants (HIV-). We correlated volumes with neuropsychological performance (NP), blood, and cerebrospinal fluid (CSF) biomarkers to examine mechanisms of and clinical associations with regional brain volumes during PHI.
Methods: CSF, blood, NP testing, and structural T1 magnetic resonance imaging scans were acquired from 18 HIV- and 48 PHI male participants. Volumetric measurements were obtained (using Freesurfer 5.1) from the following regions of interest (ROIs): caudate, amygdala, corpus callosum, ventricles, putamen, thalamus, cortical white matter, and total grey matter. Student’s t-test assessed volumetric differences in these ROIs between the two groups. Pearson correlations examined relationships during PHI between volumetric measures and biomarkers in CSF [viral load (VL), neopterin, and neurofilament light-chain (NFL)], and blood (VL, CD4+, and CD8+ T cell count), and NP tests [digit-symbol (DSST), grooved pegboard (GPD), finger-tapping (FT), and timed gait (TG)].
Results: PHI (median 106 days after estimated infection) and HIV- participants were similar in age (36.7 and 35.2 years, respectively) and education (16.1 years and 15.42 years). Only the putamen was significantly different (decreased volume) in PHI compared to HIV- (p=0.05). Within the PHI group, putamen volume associated directly with decreasing CD4+ count (p=0.004, Fig. 1A). Trends for inverse correlations were noted for CSF/plasma albumin ratio (p=0.07) and CSF NFL (p=0.09). Reductions in putamen volume in PHI participants were associated with worse performance on the DSST (p=0.05), FT (p=0.05), and TG (p=0.02, Fig. 1B) tests.
Conclusions: Our volumetric results suggest that the putamen may be specifically affected in the first year of HIV infection, and the volume of this structure associates with systemic immune measures and neurocognitive performance during this period. Longitudinal analyses are required to assess whether early introduction of ART might stabilize or reverse these structural changes observed in PHI.
Figure 1. In primary HIV infection, the volume of the putamen (in cubic milimeters) is significantly positively correlated with CD4+ T cell count (A) and inversely associated with decreasing performance on the timed gait neuropsychological task (B).